Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Painter

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Clinical Chemistry|March 10, 2001
Characteristics of an Albumin Cobalt Binding Test for assessment of acute coronary syndrome patients: a multicenter studyR H Christenson, S H Duh, W R Sanhai, et al.
Journal of Rehabilitation Research and Development|February 8, 2000
Research on physical activity and health among people with disabilities: a consensus statementR A Cooper, L A Quatrano, P W Axelson, et al.
Medrxiv : the Preprint Server for Health Sciences|June 23, 2021
Molnupiravir, an Oral Antiviral Treatment for COVID-19William Fischer, Joseph J Eron, Wayne Holman, et al.
The Journal of Infectious Diseases|August 21, 2012
Progressive vaccinia: case description and laboratory-guided therapy with vaccinia immune globulin, ST-246, and CMX001Edith R Lederman, Whitni Davidson, Harold L Groff, et al.
Science Translational Medicine|December 23, 2021
A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virusWilliam A Fischer, Joseph J Eron, Wayne Holman, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Clinical Chemistry|March 10, 2001
Characteristics of an Albumin Cobalt Binding Test for assessment of acute coronary syndrome patients: a multicenter studyR H Christenson, S H Duh, W R Sanhai, et al.
Journal of Rehabilitation Research and Development|February 8, 2000
Research on physical activity and health among people with disabilities: a consensus statementR A Cooper, L A Quatrano, P W Axelson, et al.
Medrxiv : the Preprint Server for Health Sciences|June 23, 2021
Molnupiravir, an Oral Antiviral Treatment for COVID-19William Fischer, Joseph J Eron, Wayne Holman, et al.
The Journal of Infectious Diseases|August 21, 2012
Progressive vaccinia: case description and laboratory-guided therapy with vaccinia immune globulin, ST-246, and CMX001Edith R Lederman, Whitni Davidson, Harold L Groff, et al.
Science Translational Medicine|December 23, 2021
A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virusWilliam A Fischer, Joseph J Eron, Wayne Holman, et al.
Pageof 6